Compare · 2 funds side by side · dividends reinvested

ARKG and IDNA

ARKGARK×IDNAiShares×

Versus in desk

Story of the two · Growth5Y$10,000 five years agoDividends reinvested · both on one scale$8,654IDNA · best of the two

02 / 04

ARKG and IDNA, Ranked

Today

FundFeeYieldYTD1 year3 yrs · yr5 yrs · yrWorst dropVolatilityAssetsAvg rank

iShares Genomics Immunology and Healthcare ETFSectors · Health care0.47%0.68%+58.8%+70.0%+33.2%−2.8%−10.6%30.6%$354M1.0

ARK Genomic Revolution ETFSectors · Health care0.75%0.00%+54.0%+51.3%+24.7%−10.1%−27.5%46.9%$2.2B2.0

Rank among the two1st → 2ndFee, drop and volatility: lower ranks higherAvg rank: mean of the 8 ranks · 1 is best

End-of-day Nov 5, 2026 · returns include dividends · since: ARKG 2014 · IDNA 2019

Head to Head

Swap sides Versus in desk

Head to Head

ARK Genomic Revolution ETF · $2.2B$5,859

ARKG

IDNA

iShares Genomics Immunology and Healthcare ETF · $354M$8,654

$10,000 five years ago, dividends reinvested · they hold 7.9% in common

ARKGMeasureIDNA

+54.0%Year to dateJan 1 → Nov 5+58.8%

+51.3%1 yearTotal return+70.0%

+24.7%3 years · per year$10,000 became $19,383 · $23,655+33.2%

−10.1%5 years · per year$10,000 became $5,859 · $8,654−2.8%

0.75%Expense ratio$75 · $47 a year on $10k · lower is better0.47%

0.00%Trailing 12-mo yield$0 · $68 a year on $10k0.68%

−27.5%Worst dropSmaller is better−10.6%

46.9%VolatilityLower is calmer30.6%

ARKGIDNA Winner of the row, in its colourEach row: the bigger of the two fills its side

0–8IDNA wins

End-of-day Nov 5, 2026 · returns include dividends · 3Y and 5Y figures are per-year returns

More Ways to See the Pairs

ARKG vs IDNA: Top 5 Holdings

Today

ARKG

36.0%in top 5

IDNA

in top 533.8%

ARKGStockIDNA

not top 5MRNA14.6%

9.2%TEMnot top 5

8.0%TXGnot top 5

8.0%TWST5.5%

not top 5GMAB.CO5.8%

5.5%CRSPnot top 5

5.3%ABSInot top 5

not top 5REGN3.9%

not top 5BAYN.DE3.9%

Held in common7.9%

End-of-day Nov 5, 2026 · share of each fund

ARKG vs IDNA Returns, Every Period

ARKARKG

−10.1%

5 years, per year

IDNAiShares

−2.8%

5 years, per year

ARKGIDNAFaded: behind in that period

0–4IDNA wins

End-of-day Nov 5, 2026 · dividends in · faded = behind in that period

ARKG vs IDNA

YTD

ARKARKG

+54.0%

IDNAiShares

+58.8%

+54.0%Year to date+58.8%

−27.5%Worst drop · 1Y−10.6%

46.9%Volatility · 1Y30.6%

0.0%Yield0.7%

$2.2BAssets$354M

4–0IDNA wins

End-of-day Nov 5, 2026 · smaller drop and lower volatility win

Cost, Income and Risk

Fees: ARKG, IDNA

Today

0.47%lowest, IDNA

FundExpense ratioFee$10k

IDNA0.47%$47

ARKG0.75%$75

End-of-day Nov 5, 2026 · fee on $10,000 a year

Yields: ARKG, IDNA

0.68%highest, IDNA

FundTrailing yieldYield$10k

IDNA0.68%$68

ARKG0.00%$0

End-of-day Nov 5, 2026 · trailing 12-month yield

Income After Fees on $10,000

$21most kept, IDNA

IDNA$68 − $47 = $21

ARKG$0 − $75 = −$75

KeptFee

End-of-day Nov 5, 2026 · yield in dollars minus the fee

Overlap: ARKG, IDNA

Today

7.9%most shared, ARKG and IDNA

ARKGIDNA

ARKG—7.9%

IDNA7.9%—

End-of-day Nov 5, 2026 · share held in common · outlined: the pair in versus

Return vs Bumpiness: 2 ETFs

+70.0%IDNA, at 30.6% volatility

IDNAWorst drop−10.6%30.6% vol

ARKGWorst drop−27.5%46.9% vol

End-of-day Nov 5, 2026 · up and left is better

Paid More vs Made More

YTD

IDNAARKG

+58.8%Year to date+54.0%

0.7%Yield0.0%

+70.0%Past year+51.3%

0.47%Fee0.75%

4–0IDNA wins

End-of-day Nov 5, 2026

Popular Pairs Near These Two

SCHD vs VIG

YTD

SchwabSCHD

+32.3%

VIGVanguard

+12.5%

+32.3%Year to date+12.5%

3.0%Yield1.5%

$123BAssets$109B

2–0SCHD wins

End-of-day Nov 5, 2026

JEPQ vs JEPI

YTD

J.P. MorganJEPQ

+8.5%

JEPIJ.P. Morgan

+5.2%

+8.5%Year to date+5.2%

12.2%Yield8.1%

$42.1BAssets$46.1B

2–0JEPQ wins

End-of-day Nov 5, 2026

SPYM vs SPY

YTD

SPDRSPYM

+8.4%

SPYSPDR

+8.3%

+8.4%Year to date+8.3%

1.1%Yield1.0%

$182BAssets$805B

2–0SPYM wins

End-of-day Nov 5, 2026